Northern Trust’s Krystal Biotech KRYS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$65.2M Buy
252,463
+5,020
+2% +$1.34M 0.01% 954
2025
Q4
$61M Sell
247,443
-722
-0.3% -$152K 0.01% 993
2025
Q3
$43.8M Sell
248,165
-3,243
-1% -$485K 0.01% 1220
2025
Q2
$34.6M Sell
251,408
-8,587
-3% -$1.26M ﹤0.01% 1318
2025
Q1
$46.9M Sell
259,995
-2,268
-0.9% -$381K 0.01% 1125
2024
Q4
$41.1M Buy
262,263
+23,572
+10% +$4.18M 0.01% 1242
2024
Q3
$43.4M Buy
238,691
+20,230
+9% +$3.9M 0.01% 1115
2024
Q2
$40.1M Buy
218,461
+13,383
+7% +$2.25M 0.01% 1132
2024
Q1
$36.5M Sell
205,078
-4,121
-2% -$572K 0.01% 1203
2023
Q4
$26M Sell
209,199
-4,064
-2% -$451K ﹤0.01% 1432
2023
Q3
$24.7M Buy
213,263
+4,129
+2% +$504K ﹤0.01% 1405
2023
Q2
$24.6M Buy
209,134
+7,657
+4% +$782K ﹤0.01% 1450
2023
Q1
$16.1M Buy
201,477
+189
+0.1% +$14.8K ﹤0.01% 1693
2022
Q4
$15.9M Sell
201,288
-950
-0.5% -$70.5K ﹤0.01% 1691
2022
Q3
$14.1M Buy
202,238
+1,180
+0.6% +$85.3K ﹤0.01% 1732
2022
Q2
$13.2M Buy
201,058
+6,956
+4% +$433K ﹤0.01% 1820
2022
Q1
$12.9M Buy
194,102
+10,543
+6% +$658K ﹤0.01% 1987
2021
Q4
$12.8M Buy
183,559
+2,125
+1% +$124K ﹤0.01% 2066
2021
Q3
$9.47M Sell
181,434
-7,121
-4% -$422K ﹤0.01% 2316
2021
Q2
$12.8M Buy
188,555
+9,913
+6% +$692K ﹤0.01% 2205
2021
Q1
$13.8M Buy
178,642
+5,516
+3% +$401K ﹤0.01% 2081
2020
Q4
$10.4M Sell
173,126
-4,298
-2% -$215K ﹤0.01% 2225
2020
Q3
$7.64M Buy
177,424
+12,416
+8% +$539K ﹤0.01% 2265
2020
Q2
$6.83M Buy
165,008
+16,369
+11% +$788K ﹤0.01% 2331
2020
Q1
$6.43M Buy
148,639
+9,045
+6% +$473K ﹤0.01% 2155
2019
Q4
$7.73M Sell
139,594
-3,455
-2% -$169K ﹤0.01% 2339
2019
Q3
$4.97M Buy
143,049
+103,065
+258% +$4.61M ﹤0.01% 2558
2019
Q2
$1.61M Buy
39,984
+18,560
+87% +$607K ﹤0.01% 3176
2019
Q1
$705K Sell
21,424
-421
-2% -$9.92K ﹤0.01% 3461
2018
Q4
$454K Buy
+21,845
New +$457K ﹤0.01% 3570

Other funds holding KRYS